How to Test for PCOS (and What to Expect)

What Is PCOS and Why Is Testing Complicated?

Polycystic ovary syndrome is an endocrine disorder affecting 6 to 13 percent of reproductive-age women globally, making it the most common hormonal condition in that population, according to the World Health Organization [1]. Despite that prevalence, diagnosis is routinely delayed. A 2017 survey published in Human Reproduction found that 34 percent of women with PCOS visited three or more physicians before receiving a confirmed diagnosis [2].

The complexity comes from biology. PCOS is a syndrome, not a single disease. It produces overlapping metabolic, reproductive, and dermatologic signs that vary substantially from person to person. One woman may present with absent periods and severe acne; another may have regular cycles but clear androgen excess and polycystic ovaries. Testing must account for that variability rather than hunting for one definitive marker.

Why No Single Lab Test Confirms PCOS

No blood value alone is diagnostic. Testosterone can be mildly elevated in healthy women during certain cycle phases. AMH (anti-Müllerian hormone) rises in PCOS but also varies with age and lab assay. Ultrasound follicle counts depend heavily on machine resolution and the operator's technique.

This is why the Rotterdam criteria, established at a 2003 European Society of Human Reproduction and Embryology and American Society for Reproductive Medicine consensus meeting, remain the international standard [3]. They require at least two of three features: oligo-ovulation or anovulation, clinical or biochemical signs of androgen excess, and polycystic ovarian morphology on ultrasound.

Who Should Suspect PCOS and Seek Testing

Any person with ovaries who experiences one or more of the following for longer than three months should discuss testing with a clinician:

• Menstrual cycles shorter than 21 days or longer than 35 days, or fewer than eight cycles per year
• Unexplained acne, hirsutism (excess facial or body hair), or scalp hair thinning
• Difficulty conceiving after 12 months of unprotected intercourse (or 6 months if over age 35)
• Acanthosis nigricans (darkened skin at the neck or armpits), which signals insulin resistance
• Incidental finding of "polycystic ovaries" on a pelvic ultrasound done for another reason

The Medical History and Physical Exam: Where Testing Actually Begins

Before any blood is drawn, the clinician takes a thorough history. This step is often underestimated, but it provides roughly half the diagnostic information needed under the Rotterdam framework.

Menstrual History

The clinician will ask about cycle length, flow duration, spotting, and when irregular periods first appeared. Anovulatory cycles often feel different from ovulatory ones: shorter, lighter, or unpredictably timed. A menstrual calendar app or paper diary covering the prior three months is genuinely useful to bring to this appointment.

The Endocrine Society's 2023 Clinical Practice Guideline on PCOS recommends that clinicians use cycle irregularity as the primary screening criterion in adolescents, since ovarian morphology and androgen levels are less reliable in the first two years after menarche [4].

Physical Exam Findings

The clinician looks for:

• Hirsutism: Scored using the modified Ferriman-Gallwey scale (score of 4-6 or higher, depending on ethnicity, suggests androgen excess)
• Acne: Location matters. Jaw, chin, and chest acne is more associated with androgen excess than forehead acne.
• Alopecia: Diffuse thinning at the crown (androgenic pattern)
• Acanthosis nigricans: Velvety darkened skin folds at the neck, axilla, or groin
• BMI and blood pressure: Metabolic risk stratification, not diagnostic criteria

A 2018 analysis in the Journal of Clinical Endocrinology and Metabolism found that clinician-assessed hirsutism using the Ferriman-Gallwey scale had a sensitivity of 81 percent for identifying biochemical androgen excess in women with suspected PCOS [5].

Blood Tests Used in PCOS Diagnosis

The blood panel for PCOS covers three domains: reproductive hormones, androgen markers, and metabolic markers. Expect to have between 8 and 12 separate analytes ordered at the initial workup.

Reproductive Hormones

LH and FSH. Many women with PCOS show an elevated LH-to-FSH ratio (often 2:1 or higher), but this finding is present in only about 50 to 75 percent of cases and is no longer required for diagnosis. It is still useful context [6].

Estradiol. Usually measured to assess cycle phase and rule out estrogen-secreting tumors.

Prolactin. Elevated prolactin (hyperprolactinemia) can mimic PCOS by suppressing ovulation and raising androgen production. It must be excluded. Normal fasting prolactin is generally below 25 ng/mL in women.

TSH (thyroid-stimulating hormone). Hypothyroidism causes irregular cycles and can co-exist with PCOS. A TSH above 4.0 mIU/L warrants further thyroid evaluation [7].

Androgen Panel

Total testosterone. The most commonly ordered androgen. Values above the lab's upper reference limit for women (typically 50-70 ng/dL, depending on assay) suggest hyperandrogenism. The Endocrine Society guideline recommends liquid chromatography-tandem mass spectrometry (LC-MS/MS) as the preferred assay method over immunoassay, which overestimates testosterone at low concentrations [4].

Free testosterone or free androgen index. Because testosterone binds to sex hormone-binding globulin (SHBG), total testosterone can look normal even when biologically active (free) testosterone is elevated. SHBG is often lower in PCOS, increasing free fraction.

DHEA-S (dehydroepiandrosterone sulfate). Produced almost exclusively by the adrenal glands. A markedly elevated DHEA-S (above 700 mcg/dL) suggests adrenal androgen excess or congenital adrenal hyperplasia rather than typical PCOS.

17-hydroxyprogesterone. Drawn ideally in the early follicular phase (cycle days 1-5). A value above 2 ng/mL warrants a cosyntropin stimulation test to rule out non-classic congenital adrenal hyperplasia, per Endocrine Society guidance [4].

Metabolic Markers

Fasting glucose and fasting insulin. Used to calculate HOMA-IR (Homeostatic Model Assessment of Insulin Resistance). A HOMA-IR above 2.5 suggests insulin resistance. Approximately 70 percent of women with PCOS have insulin resistance by this measure, regardless of weight [8].

HbA1c. Reflects average blood glucose over 90 days. The American Diabetes Association classifies HbA1c of 5.7-6.4% as prediabetes and 6.5% or higher as diabetes [9]. Women with PCOS have a 4-fold increased risk of type 2 diabetes compared to the general population.

Fasting lipid panel. PCOS is associated with dyslipidemia: lower HDL, higher triglycerides, and a greater proportion of small dense LDL particles. A 2011 meta-analysis in Human Reproduction Update confirmed this lipid pattern in women with PCOS across multiple ethnic groups [10].

AMH (anti-Müllerian hormone). Produced by small follicles, AMH is two to four times higher in women with PCOS than in age-matched controls. Some guidelines, including the 2018 international evidence-based PCOS guideline, suggest AMH may eventually replace ultrasound for diagnosing polycystic ovarian morphology, but it is not yet a standalone diagnostic criterion [11].

The Pelvic Ultrasound: What Happens and What Doctors Look For

Ultrasound is the imaging study of choice for evaluating ovarian morphology. It does not involve radiation. The exam takes roughly 15 to 30 minutes.

Transvaginal vs. Transabdominal Ultrasound

Transvaginal ultrasound (TVUS) places a small probe inside the vagina and provides significantly higher resolution than the abdominal approach. It is the preferred method for adults in most clinical guidelines. Transabdominal ultrasound (with a full bladder) is used instead for adolescents who have never had vaginal intercourse or who decline the transvaginal approach.

What the Ultrasound Measures

The sonographer counts antral follicles (small fluid-filled sacs, typically 2-9 mm in diameter) in each ovary and measures total ovarian volume. Per the 2018 international PCOS guideline update, polycystic ovarian morphology is defined as 20 or more follicles per ovary on TVUS with modern high-frequency probes, or an ovarian volume greater than 10 mL in either ovary, with no corpus luteum, cysts, or dominant follicle present [11].

The older 2003 Rotterdam threshold of 12 follicles per ovary was revised upward because transducer technology improved substantially, and 12 follicles is now within normal range for many women with healthy ovulatory cycles.

Timing the Ultrasound

For women with regular cycles, the ideal timing is cycle days 2 to 5 (early follicular phase), before a dominant follicle develops. For women with highly irregular cycles or amenorrhea, the scan can be performed at any time, since no dominant follicle is likely present.

Ruling Out Other Diagnoses: The Exclusion Step

Rotterdam criteria require that other causes of irregular periods and androgen excess be excluded before PCOS is confirmed. The main conditions to rule out are:

• Thyroid dysfunction: Checked via TSH
• Hyperprolactinemia: Checked via serum prolactin
• Non-classic congenital adrenal hyperplasia (NCCAH): Checked via early-morning 17-hydroxyprogesterone and, if indicated, cosyntropin stimulation test
• Cushing syndrome: Suspected if the patient has central obesity, easy bruising, wide purple striae, or proximal muscle weakness. Screened with 24-hour urinary free cortisol or late-night salivary cortisol
• Androgen-secreting tumor: Suspected when total testosterone exceeds 150-200 ng/dL or DHEA-S is markedly elevated; requires imaging

The FDA-cleared dexamethasone suppression test (1 mg overnight) is the most commonly used initial screen for Cushing syndrome in outpatient settings [12].

PCOS in Adolescents: Special Considerations

Diagnosing PCOS in teenagers (typically defined as within eight years of menarche) requires extra caution. Normal pubertal development includes anovulatory cycles, transient acne, and ovaries that can appear polycystic on ultrasound.

The 2023 Endocrine Society guideline specifies that in adolescents, both irregular cycles and biochemical hyperandrogenism must be present to diagnose PCOS. Polycystic ovarian morphology alone is not sufficient, and an ultrasound is not recommended as a primary diagnostic tool in this age group [4]. The guideline states directly: "Ultrasonographic features of PCOS should not be used as a diagnostic criterion in adolescents within 8 years of menarche."

PCOS in Perimenopausal Women: A Distinct Challenge

Diagnosing PCOS near menopause is difficult because natural cycle irregularity and rising FSH can obscure the picture. AMH levels decline with age and may fall into the normal range even in women who had PCOS throughout their reproductive years.

A prior documented PCOS diagnosis is the most reliable indicator. If records are unavailable, clinicians look for persistent hyperandrogenism and a history of chronic anovulation dating back to early adulthood. Ovarian volume also decreases with age, making ultrasound less informative after age 45.

What Happens After Diagnosis: Next Clinical Steps

A confirmed PCOS diagnosis opens a structured treatment conversation that depends on the patient's primary concern.

If the Goal Is Cycle Regulation

Combined oral contraceptives (COCs) remain first-line for menstrual regulation in women who do not want pregnancy. They suppress LH, reduce androgen production, and protect the endometrium from unopposed estrogen. The Endocrine Society guideline supports COC use specifically for this indication [4].

If the Goal Is Fertility

Letrozole 2.5-7.5 mg (cycle days 3-7) is now the preferred first-line ovulation induction agent over clomiphene citrate, based on the PPCOS II trial (N=750), which showed higher live birth rates with letrozole (27.5% vs. 19.1%, P<0.001) [13].

If Insulin Resistance Is Present

Metformin 500-2,000 mg daily improves insulin sensitivity and can restore ovulatory cycles in women with PCOS who also have insulin resistance or prediabetes. A 2012 Cochrane review (29 RCTs, N=3,763) found that metformin improved ovulation rates significantly compared to placebo [14].

Emerging data on GLP-1 receptor agonists are promising. A 2023 randomized trial in Diabetes Care (N=185) found that semaglutide 1 mg weekly reduced total testosterone by a mean of 17% and improved menstrual regularity in overweight women with PCOS over 24 weeks [15].

The table below summarizes the standard PCOS diagnostic workup in a single reference view for clinical and patient use.

| Test | What It Measures | Abnormal Signal in PCOS | |---|---|---| | Total testosterone | Androgen production | Above lab upper limit (~50-70 ng/dL) | | Free testosterone / SHBG | Bioavailable androgen | Free T elevated; SHBG suppressed | | DHEA-S | Adrenal androgen | Mild to moderate elevation | | 17-hydroxyprogesterone | NCCAH screen | >2 ng/mL triggers cosyntropin test | | LH / FSH | Pituitary signaling | LH:FSH ratio often >2:1 | | AMH | Follicle pool size | 2-4x above age-matched controls | | Fasting glucose / insulin | Insulin sensitivity | HOMA-IR >2.5 | | HbA1c | 90-day glucose average | 5.7% or higher = prediabetes | | Prolactin | Hyperprolactinemia screen | >25 ng/mL = further workup | | TSH | Thyroid function | >4.0 mIU/L = further workup | | Lipid panel | Metabolic risk | Low HDL, high triglycerides | | Pelvic ultrasound | Follicle count, ovarian volume | ≥20 follicles/ovary or volume >10 mL |

Preparing for Your PCOS Testing Appointment

A few practical steps improve the accuracy of results and reduce the chance of a repeat visit:

1. Fast for 8-12 hours before the blood draw. Water is fine. Fasting affects insulin, glucose, lipids, and some hormone levels.
2. Track your last three menstrual cycles using an app or written log. Note cycle length, duration of flow, and any spotting.
3. List all current medications and supplements. Biotin (common in hair and nail supplements) interferes with immunoassay hormone tests. Stop biotin at least 72 hours before the blood draw.
4. Ask whether your lab uses LC-MS/MS or immunoassay for testosterone. If immunoassay, request a referral to a lab that uses mass spectrometry, especially if your total testosterone is in the borderline range.
5. Bring photos of any skin changes, including acne distribution, hair growth pattern, or skin darkening, if they are not visually apparent on the day of the exam.
6. Schedule the ultrasound for cycle days 2-5 if you have a regular cycle. Confirm the window with your ordering clinician in advance.